Bolt Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-1.83; its P/E ratio is -0.61; Bolt Biotherapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 2.09M	$ 2.53M	$ 1.43M	$ 1.83M	$ 1.41M
Gross Profit	$ 2.09M	$ 2.53M	$ 1.43M	$ 1.83M	$ 1.41M
EBIT	$ -17.90M	$ -16.26M	$ -18.06M	$ -18.41M	$ -21.04M
EBITDA	$ -17.87M	-	$ -17.98M	$ -18.08M	$ -20.34M
Net Income Common Stockholders	$ -17.90M	$ -16.26M	$ -18.06M	$ -16.98M	$ -20.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 102.19M	$ 119.72M	$ 125.87M	$ 126.38M	$ 168.89M
Total Assets	$ 159.78M	$ 175.35M	$ 190.70M	$ 206.18M	$ 227.81M
Total Debt	$ 20.22M	$ 20.86M	$ 21.47M	$ 22.05M	$ 22.61M
Net Debt	$ -81.97M	$ -98.87M	$ -104.39M	$ -104.33M	$ -146.28M
Total Liabilities	$ 47.04M	$ 47.10M	$ 48.56M	$ 48.49M	$ 56.30M
Stockholders Equity	$ 112.74M	$ 128.26M	$ 142.16M	$ 157.69M	$ 171.51M
Cash Flow	-
Free Cash Flow	$ -14.27M	-	$ -15.14M	$ -23.40M	$ -18.14M
Operating Cash Flow	$ -14.27M	$ -16.75M	$ -15.11M	$ -23.40M	$ -17.95M
Investing Cash Flow	$ 15.81M	$ 12.66M	$ 13.58M	$ 28.99M	$ 16.43M
Financing Cash Flow	$ 106.00K	-	$ 147.00K	-	$ 144.00K

Currency in USD

Bolt Biotherapeutics Earnings and Revenue History

Income Statement >

Bolt Biotherapeutics Debt to Assets

Balance Sheet >

Bolt Biotherapeutics Cash Flow

Cash Flow >

Bolt Biotherapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing